Bio

Catherine Turgeon represents her clients in a broad range of U.S. and offshore investment and financing transactions, including private equity transactions, venture capital and growth equity investments, mergers and acquisitions, convertible instruments, private investments in public equity (PIPEs), special purpose acquisition companies (SPACs), joint ventures and other specialized investment structures. Catherine guides clients through investments in companies at virtually all stages of development from early-stage startups and growth-stage companies to companies preparing to go public. She assists with the entire investment life cycle, including the initial investment, follow-on and bridge investments, crossover financings, and the exit through an initial public offering (IPO), SPAC transaction, sale or merger. She counsels clients on investments, M&A, and other transactions across a wide range of industries such as life sciences, biotechnology, medical devices, pharmaceuticals, automotive technology, data technology, energy, finance, online platforms, insurance solutions, social media and software. Catherine applies a commercial approach in advising clients, with the goal of minimizing risks and realizing returns, while protecting their economic interests in an exit transaction. She also counsels clients on general corporate and regulatory matters.